<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Human leukocyte antigen (HLA)-E can contribute to the escape of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells from host immune mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is unknown whether HLA-E gene polymorphisms might play a role in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> immune escape </plain></SENT>
<SENT sid="2" pm="."><plain>This study aimed to evaluate the correlation between HLA-E gene polymorphisms and HLA-E expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue and determine the effects on clinical outcome of patients with <z:e sem="disease" ids="C0677949" disease_type="Neoplastic Process" abbrv="">stage III colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Two hundred thirty patients with <z:e sem="disease" ids="C0677949" disease_type="Neoplastic Process" abbrv="">stage III colorectal cancer</z:e> were enrolled </plain></SENT>
<SENT sid="4" pm="."><plain>HLA-E expression was detected in patient-derived <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues with immunohistochemistry </plain></SENT>
<SENT sid="5" pm="."><plain>HLA-E gene alleles in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues were detected with the polymerase chain reaction-sequence-specific primer method </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissue and in the <z:mpath ids='MPATH_458'>normal</z:mpath> tissue adjacent to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, the HLA-E expression rates were 72.2 and 15.1 %, respectively (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with overexpression, low expression, and no expression of HLA-E exhibited disease-free survival of 55.3, 72.9, and 72.1 %, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with HLA-E overexpression exhibited the lowest long-term survival rate </plain></SENT>
<SENT sid="9" pm="."><plain>No relationship was observed between the type of HLA-E gene polymorphism and its expression level in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues; moreover, no polymorphisms appeared to affect the long-term survival of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The type of HLA-E polymorphism did not have an impact on HLA-E expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> or the prognosis in patients with <z:e sem="disease" ids="C0677949" disease_type="Neoplastic Process" abbrv="">stage III colorectal cancer</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>However, the level of HLA-E expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue strongly predicted long-term survival in these patients </plain></SENT>
</text></document>